Recruiting

1/2

210

Europe, US, RoW

CPI-0209

Constellation Pharmaceuticals

Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Lymphoma, T-Cell, Mesothelioma, Malignant, Prostatic Neoplasms, Castration-Resistant, Endometrial Cancer, Ovarian Clear Cell Carcinoma

12/25

03/26